EUVIMEDEUVIMED entdecken
Crossref

Role of J stent as a minimally invasive treatment option for ureteropelvic junction obstruction

Murat Yavuz Koparal, Burak Elmas, Serhat Gurocak, Cihat Aytekin, Mustafa Ozgur Tan

Canadian Journal of Urology · 2025

DOI: 10.32604/cju.2025.063616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Urology, 2025. Verfasst von Murat Yavuz Koparal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Gazi University, Ankara, 06560, Turkey. Hauptthemen laut MEDLINE: Ureteral Obstruction, Stents, Kidney Pelvis. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: The aim of this study was to investigate the factors affecting treatment success in children that got either pyeloplasty or J stent placement in ureteropelvic junction obstruction (UPJO). PATIENTS AND METHODS: The study comprised 126 patients who either J stent placement or pyeloplasty performed by the same physician for UPJO from 2012 to 2022. The criteria for surgical intervention adhered to the European Association of Urology (EAU) recommendations. Symptomatic patients with verified obstruction, with a split renal function (SRF) over 40%, low-grade hydronephrosis (Society of Fetal Urology grade 2), and an obstructive segment measuring less than 1 cm, had Double-J stent placement. Furthermore, in infants exhibiting poor health or development retardation, a J stent was inserted as a temporary measure to alleviate obstruction and maintain renal function, notwithstanding the recommendation for pyeloplasty. RESULTS: The treatment success rate was 43.9% in the J stent group and 88.4% in the pyeloplasty group, with a statistically significant difference (p < 0.001). The kind of procedure (pyeloplasty vs. stent) was the sole independent prognostic factor predicting treatment success (HR: 4.77, p < 0.001) in the multiple logistic regression analysis. No statistically significant change was observed in preoperative and postoperative SRF (48% vs. 48.5%, p = 0.923) among patients with stent failure, confirming a transient preservation of functional advantage. CONCLUSION: The placement of a stent may have restricted success rates in specific patients with UPJO. Preserving renal function may be advantageous until definitive surgery, particularly in cases where there are hazards associated with anesthesia and invasive procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ureteral ObstructionStentsKidney PelvisHumansFemaleMaleInfantChild, PreschoolRetrospective StudiesChildTreatment OutcomeMinimally Invasive Surgical ProceduresUrologic Surgical Procedures

Stichwörter der Autor:innen

hydronephrosistreatmentureteropelvic junction obstruction

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, Gazi University, Ankara, 06560, Turkey.
  • Urology Clinic, Kizilcahamam State Hospital, Ankara, 06890, Turkey.

Zitieren

APA

Koparal, M. Y., Elmas, B., Gurocak, S., Aytekin, C., & Tan, M. O. (2025). Role of J stent as a minimally invasive treatment option for ureteropelvic junction obstruction. Canadian Journal of Urology. https://doi.org/10.32604/cju.2025.063616

Vancouver

Koparal MY, Elmas B, Gurocak S, Aytekin C, Tan MO. Role of J stent as a minimally invasive treatment option for ureteropelvic junction obstruction. Canadian Journal of Urology. 2025. doi:10.32604/cju.2025.063616

BibTeX
@article{Koparal2025,
  author = {Koparal, Murat Yavuz and Elmas, Burak and Gurocak, Serhat and Aytekin, Cihat and Tan, Mustafa Ozgur},
  title = {Role of J stent as a minimally invasive treatment option for ureteropelvic junction obstruction},
  journal = {Canadian Journal of Urology},
  year = {2025},
  doi = {10.32604/cju.2025.063616}
}
Kostenlos starten →